Beobachten
- Press release BoxID 520133
BioWelder® TC: Fully Automated Device for Welding Large and Liquid-Filled TPE Tubing
(PresseBox) (Goettingen/Aubagne, France, )
Sartorius Stedim Biotech, a leading international supplier for the pharma and biotech industries, has launched the BioWelder® Total Containment (TC). BioWelder® TC featuring innovative technology permits sterile connection of liquid-filled thermoplastic tubing that has an outer diameter (OD) of up to 1 inch and that is used on disposable bags or bag assemblies in all biopharmaceutical manufacturing processes. The sterile welding process is fully automated and can be performed in non- classified or classified environments while maintaining product sterility.
The thermal weld produced by BioWelder® TC ensures an extraordinary level of stability, thus guaranteeing an ultra-safe connection. The thermal weld has been qualified by applying the most stringent and innovative test regimes. Biological, physical and extractables tests were combined to obtain data representing a variety of process conditions, including critical applications.
The thermal weld produced by BioWelder® TC ensures an extraordinary level of stability, thus guaranteeing an ultra-safe connection. The thermal weld has been qualified by applying the most stringent and innovative test regimes. Biological, physical and extractables tests were combined to obtain data representing a variety of process conditions, including critical applications.
About Sartorius AG
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of "turning science into solutions."
Headquartered in Aubagne, France, Sartorius Stedim Biotech is listed on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany. The company employs approx. 2,850 people, and in 2011 earned sales revenue of 477.3 million euros.
You might also be interested in
|
Roche's Rapid Mycoplasma Detection Test MycoTOOL Receives Acceptance from Canadian Authorities for Release Testing of Biopharmaceutical Roche Product
, Biotechnology, Roche Diagnostics GmbH
Today Roche announced that the Canadian Health Authority has accepted the use of its PCR based mycoplasma detection test MycoTOOL for release testing of one of Roche's...
|
Rohstofflieferant Meer
Eine sichere Rohstoffversorgung ist für die deutsche Industrie von existenzieller Bedeutung. Aufgrund der stetig wachsenden Nachfrage von Rohstoffen stellt der Abbau...
|
|
Roche Launches New Bead Based DNA Target Enrichment Reagent Kit for Next Generation Sequencing
, Biotechnology, Roche Diagnostics GmbH
Roche today announced the global launch of its SeqCap EZ Pure Capture Bead Kit supporting target enrichment workflows prior to DNA sequencing. The newly introduced...
